NEW
Omjjara

Omjjara Overdosage

Manufacturer:

Patheon

Distributor:

Zuellig

Marketer:

GlaxoSmithKline
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Overdosage
If overdose is suspected, the patient should be monitored for any signs or symptoms of adverse reactions or effects, and appropriate standard of care measures should be instituted immediately. Further management should be as clinically indicated. Haemodialysis is not expected to enhance the elimination of momelotinib.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in